Arora, Rohit
Cao, Christian
Kumar, Mehul
Sinha, Sarthak http://orcid.org/0000-0002-0770-3150
Chanda, Ayan http://orcid.org/0000-0002-2692-8558
McNeil, Reid
Samuel, Divya
Arora, Rahul K. http://orcid.org/0000-0003-3526-6338
Matthews, T. Wayne
Chandarana, Shamir
Hart, Robert
Dort, Joseph C.
Biernaskie, Jeff
Neri, Paola
Hyrcza, Martin D.
Bose, Pinaki http://orcid.org/0000-0002-8338-2838
Funding for this research was provided by:
PRecision Oral Biology (PROBE) Grant from the Ohlson Research Initiative and Charbonneau Cancer Institute
Article History
Received: 31 October 2022
Accepted: 19 July 2023
First Online: 18 August 2023
Competing interests
: R.A. was a bioinformatics consultant at Phenomic AI. R.K.A was previously a Venture Fellow at Flagship Pioneering. R.K.A has served as a Technical Consultant for the Bill and Melinda Gates Foundation Strategic Investment Fund and was a former Senior Policy Advisor at Health Canada. R.K.A also holds a minority stake in Alethea Medical. P.B. is the co-founder and Vice President of Management and Planning at OncoHelix, Inc. All other study authors declare no competing interests.